MOONLAKE IMMUNOTHERAPEUTICS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.92 USD | -2.50% |
|
-9.59% | -32.24% |
| May. 07 | MoonLake Immunotherapeutics Q1 Net Loss Widens | MT |
| May. 07 | MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar MoonLake Immunotherapeutics
670972f0c52726f25.ENoqZaIu83eijGhZgKEDzK6nhmASoZy8ELbfDBPCB0g.PY14AfsZow3l7yBhx_RnucaXsQVry874dsyFdEODVxB8638xyVacR5LbAw~c2290eddc6d2fd912c9ac98af022954d
Upcoming events on MoonLake Immunotherapeutics
Past events on MoonLake Immunotherapeutics
| 2024-05-07 08:00 am | Q1 2024 Earnings Release |
| 2024-04-15 | Van Lanschot Kempen Life Sciences Conference |
| 2024-03-11 | Barclays Global Healthcare Conference |
| 2024-03-10 | Leerink Partners Global Biopharma Conference |
| 2024-03-10 05:00 pm | American Academy of Dermatology Meeting |
| 2024-03-10 12:00 pm | R&D Day |
| 2024-03-03 | TD Cowen Health Care Conference |
| 2024-02-29 08:00 am | Q4 2023 Earnings Release |
| 2024-01-07 | JPMorgan Healthcare Conference |
| 2023-11-14 08:00 am | Q3 2023 Earnings Release |
| 2023-11-13 | Jefferies London Healthcare Conference |
| 2023-11-09 | American College of Rheumatology Conference |
| 2023-11-07 | UBS Biopharma Conference |
| 2023-11-06 08:00 am | R&D Day |
| 2023-11-05 | Guggenheim Securities Inflammation & Immunology Conference |
| 2023-10-16 08:00 am | R&D Day |
| 2023-09-25 | Cantor Global Healthcare Conference |
| 2023-09-18 | Stifel Immunology & Inflammation Virtual Summit |
| 2023-09-11 11:30 am | Capital Markets Day |
| 2023-09-05 | Wells Fargo Healthcare Conference |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -55,4 -66,0 16.07% | -54,1 -52,9 -2.35% | -80,3 |
|
EBIT Million USD | Released Forecast Spread | -65,1 -61,3 -6.06% | -54,1 -53,8 -0.68% | -97,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -64,5 -63,4 -1.66% | -44,0 -50,4 12.68% | -78,9 |
|
Net income Million USD | Released Forecast Spread | -50,0 -56,3 11.17% | -36,0 -45,5 20.89% | -75,4 |
|
EPS USD | Released Forecast Spread | -1,70 -1,48 -15.2% | -0,73 -0,93 21.54% | -1,14 |
| Announcement Date | 20/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -15,0 -13,8 -9.01% | -19,8 -16,3 -21.45% | -18,8 | -23,8 | -29,0 | ||||||||
|
EBIT Million USD | Released Forecast Spread | -17,7 -17,3 -2.33% | -14,8 -19,1 22.67% | -16,7 -16,7 0.14% | -12,9 -15,6 17.24% | -13,2 -14,0 5.57% | -13,0 -15,0 13.34% | -15,0 -14,8 -1.87% | -19,8 -17,2 -15.54% | -22,4 | -27,6 | -33,6 | -33,4 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,4 -17,2 -1.27% | -14,7 -19,0 22.57% | -16,5 -17,1 3.6% | -12,2 -15,1 19.27% | -12,3 -13,5 8.59% | -11,6 -13,3 13% | -7,84 -13,9 43.75% | -13,9 -13,9 0.04% | -24,0 | -28,0 | -33,0 | ||
|
Net income Million USD | Released Forecast Spread | -2,70 | -17,4 -17,2 -1.32% | -10,1 -16,4 38.33% | -17,1 -14,8 -15.43% | -9,00 -14,2 36.63% | -10,1 -12,1 16.28% | -11,6 -12,2 5.1% | -7,44 -12,6 40.93% | -13,7 -11,9 -14.7% | -19,5 | -22,5 | -25,3 | |
|
EPS USD | Released Forecast Spread | -0,34 -0,54 37.04% | -0,27 -0,34 21.17% | -0,43 -0,33 -31.44% | -0,23 -0,31 25.81% | -0,23 -0,25 9.61% | -0,18 -0,22 19.28% | -0,12 -0,22 45.26% | -0,22 -0,20 -10.15% | -0,28 | -0,33 | -0,38 | ||
| Announcement Date | 16/05/22 | 12/08/22 | 14/11/22 | 20/03/23 | 11/05/23 | 10/08/23 | 14/11/23 | 29/02/24 | 07/05/24 | - | - | - | - |
More events
Past sector events for MoonLake Immunotherapeutics
| 2024-05-10 04:02 pm | CASSAVA SCIENCES, INC.: Q1 2024 Earnings Release |
| 2024-05-10 08:26 am | ITEOS THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-10 08:00 am | PRIME MEDICINE, INC.: Q1 2024 Earnings Release |
| 2024-05-10 07:00 am | AKERO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 08:05 pm | SOLENO THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 04:15 pm | ANAPTYSBIO, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:10 pm | ASTRIA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:09 pm | XENCOR, INC.: Q1 2024 Earnings Release |
| 2024-05-09 04:05 pm | STRUCTURE THERAPEUTICS INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MLTX Stock
- Calendar MoonLake Immunotherapeutics